Marketplace Stories

Washington regulators are debating a ban on Chinese telecom hardwire, but rural America may pay the price.

In some hospitals, you could pay thousands of dollars just to sit in the waiting room.

If you took some time over the holidays to catch a movie or two, chances are you sat through a lot of stuff that was not the movie, but a list of names on a screen. You get the pre-movie credits, you get the post-movie credits, which might have an Easter egg hidden in them, […]

The latest jobs numbers suggest that more people are looking for work, with the labor force participation rate ticking up a bit in December. So who’s looking for work, and what’s driving them back into the job market? To find out, we talked to some people who are looking for a job and some who […]

Employers added 312,000 jobs in December, according to the Labor Department. That’s far more jobs than expected. And yet, the unemployment rate rose from 3.7 to 3.9 percent. More jobs, higher unemployment. How’s that work? It has something to do with the labor force participation rate. Click the audio player above to hear the full […]

The Labor Department’s jobs report for December was unequivocally strong, but it can be hard to square a good month of hiring with predictions of an economic slowdown and the market turbulence as of late. But when it comes to economic data, there’s a difference between learning how the economy’s been doing and how the […]

Robert Kaplan, the president of the Federal Reserve Bank of Dallas, on Thursday told Bloomberg that the Fed ought to think about slowing down how quickly it’s shrinking its balance sheet. What’s a balance sheet? It’s a ledger of the Fed’s assets and liabilities that, in the middle of the financial crisis, the Fed expanded as […]

Bristol-Myers Squibb announced Thursday that it’s going to acquire another drugmaker, Celgene. The deal is worth about $74 billion. The combined company will have nine products with sales of more than a billion dollars a year, including some blockbuster cancer drugs. The merger is a sign that Big Pharma is betting big on cancer medications. […]